EFR3A and hearing loss disorder: Efr3a KD temporarily suppressed the rapid loss of hearing ability, and the progressive and relatively slower degenerative alterations in SGNs in the model of hearing loss, indicating Efr3a KD produced a beneficial effect against the neurodegeneration of SGNs induced by aminoglycoside antibiotics.